Clinical trials
Terminated Phase 2 Diabetes Mellitus trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
54 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 2 |
| 2006 | 3 |
| 2007 | 5 |
| 2008 | 6 |
| 2009 | 2 |
| 2010 | 4 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 54 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 3 |
| Pfizer | 3 |
| AstraZeneca | 2 |
| Loyola University | 2 |
| Novartis Pharmaceuticals | 2 |
| Takeda | 2 |
| Wyeth is now a wholly owned subsidiary of Pfizer | 2 |
| Adaptive Phage Therapeutics, Inc. | 1 |
| Akros Pharma Inc. | 1 |
| Albert Einstein College of Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus | 54 |
| Diabetes Mellitus, Type 2 | 17 |
| Diabetes Mellitus, Type 1 | 8 |
| Glucose Metabolism Disorders | 5 |
| Obesity | 5 |
| Diabetes Complications | 4 |
| Diabetic Neuropathies | 4 |
| Diabetic Retinopathy | 3 |
| Hypertension | 3 |
| Insulin Resistance | 3 |
Trials
Showing 1 to 25 of 54. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.